These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15296675)

  • 1. Fluorescently labeled adenovirus with pIX-EGFP for vector detection.
    Le LP; Everts M; Dmitriev IP; Davydova JG; Yamamoto M; Curiel DT
    Mol Imaging; 2004 Apr; 3(2):105-16. PubMed ID: 15296675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adenoviral vectors by flow cytometry.
    Weaver LS; Kadan MJ
    Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.
    Ugai H; Wang M; Le LP; Matthews DA; Yamamoto M; Curiel DT
    J Mol Biol; 2010 Jan; 395(1):55-78. PubMed ID: 19853616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations.
    Murakami M; Ugai H; Wang M; Belousova N; Dent P; Fisher PB; Glasgow JN; Everts M; Curiel DT
    Virology; 2010 Nov; 407(2):196-205. PubMed ID: 20828776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
    Li J; Le L; Sibley DA; Mathis JM; Curiel DT
    Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein.
    Le LP; Li J; Ternovoi VV; Siegal GP; Curiel DT
    J Gen Virol; 2005 Dec; 86(Pt 12):3201-3208. PubMed ID: 16298964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing E1 deleted adenoviral vector by homologous recombination.
    Zamani A; Ghannad MS
    Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
    Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ
    J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.
    Murakami M; Ugai H; Belousova N; Pereboev A; Dent P; Fisher PB; Everts M; Curiel DT
    Prostate; 2010 Mar; 70(4):362-76. PubMed ID: 19902467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
    Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
    J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
    Krougliak V; Graham FL
    Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
    Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
    J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.
    Corjon S; Gonzalez G; Henning P; Grichine A; Lindholm L; Boulanger P; Fender P; Hong SS
    PLoS One; 2011; 6(5):e18205. PubMed ID: 21637339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.
    Poulin KL; McFall ER; Chan G; Provost NB; Christou C; Smith AC; Parks RJ
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32522855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
    Campos SK; Parrott MB; Barry MA
    Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.